FDA Adverse Event
Injury
Summary report: N
THV 1000-23 3F AORTIC BIO 23MM
MDR report key: 8094457
·
Received November 21, 2018
Report
- Report Number
- 2025587-2018-03153
- Event Type
- Injury
- Date Received
- November 21, 2018
- Date of Event
- October 23, 2018
- Report Date
- November 21, 2018
- Manufacturer
- MEDTRONIC 3F THERAPEUTICS, INC.
- Product Code
- LWR
- UDI-DI
- 00613994868237
- PMA / PMN Number
- P060025
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
CONCLUSION: THE COMMON PROBABLE CAUSE FOR STENOSIS IS PANNUS. THIS FINDING IS GENERALLY CONSIDERED A PATIENT-RELATED CONDITION. WITHOUT THE RETURN OF THE PRODUCT, NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATION. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
Description of Event or Problem · 1
MEDTRONIC RECEIVED INFORMATION THAT 8 YEARS AND 1 MONTH POST IMPLANT OF THIS AORTIC BIOPROSTHETIC VALVE, A TRANSCATHETER VALVE WAS IMPLANTED VALVE-IN-VALVE DUE TO STENOSIS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 937059 | THV 1000-23 3F AORTIC BIO 23MM | HEART-VALVE, NON-ALLOGRAFT TISSUE | LWR | MEDTRONIC 3F THERAPEUTICS, INC. | 1000-23 | 00613994868237 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 81 YR | Required Intervention |